Healthcare provider profile · identity verified

Neyvis C Taboada, M.D.

Internal Medicine · MIAMI, FL · NPI 1881981876

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	948	271
Losartan Potassium	Losartan Potassium	901	218
Amlodipine Besylate	Amlodipine Besylate	736	201
Rosuvastatin Calcium	Rosuvastatin Calcium	726	194
Gabapentin	Gabapentin	665	164
Metformin Hcl	Metformin Hcl	569	150
Vitamin D2	Ergocalciferol (Vitamin D2)	553	190
Omeprazole	Omeprazole	544	168
Levothyroxine Sodium	Levothyroxine Sodium	538	145
Lisinopril	Lisinopril	474	117
Fluticasone Propionate	Fluticasone Propionate	348	122
Famotidine	Famotidine	338	118
Folic Acid	Folic Acid	324	106
Xarelto	Rivaroxaban	320	49
Furosemide	Furosemide	297	94
Hydrochlorothiazide	Hydrochlorothiazide	273	95
Albuterol Sulfate Hfa	Albuterol Sulfate	272	60
Metoprolol Succinate	Metoprolol Succinate	270	82
Metoprolol Tartrate	Metoprolol Tartrate	242	69
Tamsulosin Hcl	Tamsulosin Hcl	233	68
Pantoprazole Sodium	Pantoprazole Sodium	231	69
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	226	81
Alendronate Sodium	Alendronate Sodium	198	77
Glipizide	Glipizide	197	45
Simvastatin	Simvastatin	171	52
Trazodone Hcl	Trazodone Hcl	166	61
Warfarin Sodium	Warfarin Sodium	149	suppressed
Metformin Hcl Er	Metformin Hcl	141	37
Atenolol	Atenolol	139	33
Benzonatate	Benzonatate	133	77
Clopidogrel	Clopidogrel Bisulfate	133	39
Eliquis	Apixaban	129	27
Buspirone Hcl	Buspirone Hcl	125	46
Alprazolam	Alprazolam	107	20
Montelukast Sodium	Montelukast Sodium	107	34
Diclofenac Sodium	Diclofenac Sodium	100	47
Mupirocin	Mupirocin	100	57
Hydrocortisone	Hydrocortisone	99	34
Sildenafil Citrate	Sildenafil Citrate	99	21
Mirtazapine	Mirtazapine	98	28
Carvedilol	Carvedilol	97	32
Hydralazine Hcl	Hydralazine Hcl	94	19
Finasteride	Finasteride	93	26
Comfort Ez Pen Needle	Pen Needle, Diabetic	89	28
Ketoconazole	Ketoconazole	85	23
Nifedipine Er	Nifedipine	84	27
Ammonium Lactate	Ammonium Lactate	83	32
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	81	22
Quetiapine Fumarate	Quetiapine Fumarate	74	18
Triamcinolone Acetonide	Triamcinolone Acetonide	70	24
Alogliptin	Alogliptin Benzoate	65	13
Ibuprofen	Ibuprofen	62	24
Escitalopram Oxalate	Escitalopram Oxalate	61	25
Loperamide	Loperamide Hcl	61	15
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	60	suppressed
Azelastine Hcl	Azelastine Hcl	59	17
Dapagliflozin	Dapagliflozin Propanediol	59	15
Pravastatin Sodium	Pravastatin Sodium	58	19
Glipizide Er	Glipizide	57	17
Citalopram Hbr	Citalopram Hydrobromide	55	16
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	54	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	54	12
Temazepam	Temazepam	54	11
Azithromycin	Azithromycin	51	48
Entresto	Sacubitril/Valsartan	51	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	49	12
Silver Sulfadiazine	Silver Sulfadiazine	49	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	48	31
Sertraline Hcl	Sertraline Hcl	45	16
Donepezil Hcl	Donepezil Hcl	44	16
Doxycycline Monohydrate	Doxycycline Monohydrate	44	37
Lovastatin	Lovastatin	44	suppressed
Single Use Swab	Alcohol Antiseptic Pads	43	12
Allopurinol	Allopurinol	40	13
Prednisone	Prednisone	40	20
Solifenacin Succinate	Solifenacin Succinate	40	14
Dutasteride	Dutasteride	38	suppressed
Potassium Chloride	Potassium Chloride	37	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Verapamil Hcl	Verapamil Hcl	36	suppressed
Memantine Hcl	Memantine Hcl	35	11
Nyamyc	Nystatin	35	14
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	34	34
Spironolactone	Spironolactone	34	suppressed
Clonazepam	Clonazepam	32	12
Irbesartan	Irbesartan	32	suppressed
Ciclopirox	Ciclopirox	31	12
Enalapril Maleate	Enalapril Maleate	31	suppressed
Naproxen	Naproxen	31	24
Tramadol Hcl	Tramadol Hcl	31	suppressed
Ipratropium Bromide	Ipratropium Bromide	30	suppressed
Fenofibrate	Fenofibrate	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	14
Trijardy Xr	Empaglifloz/Linaglip/Metformin	29	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	22
Bumetanide	Bumetanide	26	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	26	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	26	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	25
Alfuzosin Hcl Er	Alfuzosin Hcl	23	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Tradjenta	Linagliptin	23	suppressed
Arnuity Ellipta	Fluticasone Furoate	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Celecoxib	Celecoxib	21	13
Ezetimibe	Ezetimibe	21	suppressed
Nystatin	Nystatin	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Baclofen	Baclofen	20	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	20	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	18	suppressed
Cilostazol	Cilostazol	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Mometasone Furoate	Mometasone Furoate	18	13
Trulicity	Dulaglutide	18	suppressed
Dapagliflozin-Metformin Er	Dapaglifloz Propaned/Metformin	17	suppressed
Fluorometholone	Fluorometholone	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Valsartan	Valsartan	17	suppressed
Cephalexin	Cephalexin	16	13
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Lactulose	Lactulose	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Comfort Ez Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	14	suppressed
Repaglinide	Repaglinide	14	suppressed
Bicalutamide	Bicalutamide	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	13	suppressed
Methimazole	Methimazole	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Calcium Acetate	Calcium Acetate	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Ozempic	Semaglutide	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Amoxicillin	Amoxicillin	11	11
Anastrozole	Anastrozole	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Insulin Aspart	Insulin Aspart	11	suppressed
Insulin Glargine Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Unithroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error